-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Inhibrx Biosciences, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q4 2024 to Q3 2025.
- Inhibrx Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending September 30, 2025 was $1.49M.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)